Research location
Montpellier
Hérault, France
Advertisement
Research activity in Montpellier
Hérault, FranceCureCurrent currently publishes aggregate city-level research activity for this location: 127 trials and 134 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Montpellier
49 linked trials · page 1 of 1A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)NCT07361497 · 2026-03-16 · 1 site observation
RECRUITING
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)NCT07361510 · 2026-03-12 · 1 site observation
RECRUITING
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP DeletionNCT07063745 · 2026-01-02 · 1 site observation
RECRUITING
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast CancerNCT07085767 · 2025-11-03 · 1 site observation
RECRUITING
National Cohort of Subjects at Risk of Developing Rheumatoid ArthritisNCT06876064 · 2025-10-07 · 1 site observation
RECRUITING
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)NCT06926868 · 2025-09-11 · 1 site observation
RECRUITING
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.NCT07062965 · 2025-08-05 · 1 site observation
RECRUITING
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)NCT06991257 · 2025-06-19 · 1 site observation
RECRUITING
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)NCT06875310 · 2025-04-24 · 1 site observation
RECRUITING
Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer SurgeryNCT06265558 · 2025-04-15 · 2 site observations
RECRUITING
Study of Sexual Quality of Life in Women With Breast Cancer Who Had Multidisciplinary Management With Photobiomodulation for Genitourinary Syndrome of the MenopauseNCT06347926 · 2025-03-13 · 1 site observation
RECRUITING
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).NCT06646276 · 2025-02-25 · 1 site observation
RECRUITING
Benefits of Epithelial Repair in COPD by Induced Pluripotent Stem Cells (iPS)NCT06755008 · 2025-02-19 · 1 site observation
RECRUITING
Sleep Impairment in Subjects at Risk of Developing Alzheimer's DiseaseNCT05649514 · 2025-02-05 · 1 site observation
RECRUITING
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid TumorsNCT06618287 · 2025-02-04 · 1 site observation
RECRUITING
Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's DiseaseNCT06688968 · 2025-02-04 · 3 site observations
RECRUITING
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint InhibitorNCT06472245 · 2024-12-03 · 1 site observation
RECRUITING
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%NCT06561386 · 2024-10-07 · 1 site observation
RECRUITING
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceNCT06492616 · 2024-09-27 · 1 site observation
RECRUITING
Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic ShockNCT04020263 · 2023-07-03 · 1 site observation
RECRUITING
Strengthening, Guidance, Health, EmpowermentNCT07788599 · 2026-09-01 · 1 site observation
NOT_YET_RECRUITING
Impact of the Intraoperative Use of Amines in Breast Cancer Surgery on Tumor RecurrenceNCT07624734 · 2025-12-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe AsthmaNCT07120503 · 2025-07-24 · 1 site observation
ACTIVE_NOT_RECRUITING
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsNCT06553027 · 2024-09-20 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's SyndromeNCT06312020 · 2024-05-09 · 1 site observation
TERMINATED
A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.NCT06206837 · 2024-02-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive DisorderNCT06058039 · 2023-12-21 · 1 site observation
COMPLETED
Study to Assess the Safety and Effectiveness of NMRA-335140-501NCT06029439 · 2023-11-10 · 1 site observation
TERMINATED
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)NCT05869955 · 2023-09-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Effect of Walking With Music in Obese People (BeatMove)NCT06486961 · 2023-02-10 · 1 site observation
UNKNOWN
Comparative Evaluation of the Evolution of Emerging Biological Markers in Patients Hospitalized for Acute Heart Failure According to Conventional Management or Therapeutic Adjustment Via Daily Ultrasound.NCT05297630 · 2022-02-15 · 1 site observation
COMPLETED
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)NCT04961996 · 2021-08-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Pain Monitoring After Breast Biopsy: Benefit of E-healthNCT04456920 · 2021-02-09 · 1 site observation
COMPLETED
Synthetic Metabolic and Genetic Networks for Medical DiagnosicsNCT04518072 · 2021-01-06 · 1 site observation
TERMINATED
BeatPark: Self-rehabilitation in Walking With Parkinson's DiseaseNCT04543058 · 2020-09-01 · 1 site observation
UNKNOWN
Immune Activation as a Cause of Insulin Resistance in Adults Living With HIV-1 on Effective Antiretroviral TherapyNCT04028882 · 2020-03-03 · 1 site observation
TERMINATED
A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung CancerNCT04194944 · 2020-02-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Management of Perioperative Anxiety by the Cardiac Coherence Technique Coupled With a Hypnosis SessionNCT03981731 · 2020-02-14 · 1 site observation
COMPLETED
Pre Pectoral Implant for Immediate Breast Reconstruction Using Single Port Endoscopy in Prophylactic IndicationNCT03838549 · 2019-04-26 · 1 site observation
COMPLETED
A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)NCT03496207 · 2018-06-13 · 1 site observation
COMPLETED
Sevoflurane in Chronic Obstructive Pulmonary Disease ExacerbationNCT03460015 · 2018-03-01 · 1 site observation
TERMINATED
Resistance to Oral Therapy in Lung CancerNCT04546282 · 2017-07-01 · 1 site observation
COMPLETED
A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast CancerNCT02779751 · 2016-11-14 · 1 site observation
ACTIVE_NOT_RECRUITING
Observational Study of Obstructive Lung Disease (NOVELTY)NCT02760329 · 2016-07-25 · 1 site observation
COMPLETED
Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis PatientsNCT02547493 · 2016-03-03 · 1 site observation
COMPLETED
Impact of Food Carbohydrate and Insulin Dose Computing by on Smart Phone on Glucose Control in Patients With DiabetesNCT02676609 · 2016-02-01 · 1 site observation
COMPLETED
Characterization of Breg CellsNCT02615951 · 2015-10-02 · 1 site observation
COMPLETED
A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)NCT02411448 · 2015-05-06 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics)NCT02013297 · 2013-12-03 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.